Characterization and Drug Sensitivity Testing of HTS-Compatible Cancer Microtissues

Although the advantages of organotypic 3D microtissue models have been known for years, complex production and readout processes hampered its implementation into an industrial setting. This study presents a novel method to produce organotypic, scaffold-free cancer microtissues models (0.1-1mmin diameter) and its implementation in an automated screening process.